CID 51001932
Taselisib
Structural Information
- Molecular Formula
- C24H28N8O2
- SMILES
- CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C
- InChI
- InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33)
- InChIKey
- BEUQXVWXFDOSAQ-UHFFFAOYSA-N
- Compound name
- 2-methyl-2-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propanamide
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 461.24080 | 211.6 |
[M+Na]+ | 483.22274 | 221.4 |
[M+NH4]+ | 478.26734 | 214.3 |
[M+K]+ | 499.19668 | 224.4 |
[M-H]- | 459.22624 | 213.7 |
[M+Na-2H]- | 481.20819 | 214.3 |
[M]+ | 460.23297 | 213.5 |
[M]- | 460.23407 | 213.5 |